Latest Articles
-
These Stocks Are Better Priced Compared To Abbott
We believe that there are other stocks in the healthcare sector that are currently better valued than Aboott Laboratories (NYSE: ABT) . Abbott’s current price-to-operating income ratio (P/EBIT) of 30x is much higher than levels of under 12x...
-
What’s Next For Abbott Stock After A 10% Drop Yesterday?
[Updated: 6/2/2021] Abbott Revised Guidance The stock price of Abbott (NYSE:ABT) has seen a large 10% drop over the last five trading days. The decline can be attributed to the company’s announcement of revised earnings guidance for th...
-
After A Large Decline Is Quidel A Better Bet Compared To Abbott Stock?
We think that Quidel (NASDAQ:QDEL) currently is a better pick compared to Abbott (NYSE:ABT) . QDEL stock trades at about 3.1x trailing revenues, compared to around 5.6x for Abbott. Does this gap in Quidel’s valuation make sense? To some ...
-
Forecast Of The Day: Abbott’s Diagnostics Revenue
What? Abbott (NYSE:ABT) Diagnostics Revenue rose from around $7.7 billion in 2019 to $10.8 billion in 2020. We expect the number to rise further to $15 billion in 2021 although it is likely to see a decline in 2022. Why? The surge in revenue ...
-
Here’s Why We Think Abbott Stock Will Rise Post Q1
Abbott stock (NYSE: ABT) is scheduled to report its Q1 2021 results on Tuesday, April 20. We expect Abbott to report revenues in-line and earnings above the consensus estimates, driven by continued demand for Covid-19 testing, along with a reboun...
-
Despite A 2X Rise Over The Last Year Abbott Stock Still Looks Attractive At $120
Abbott Labs (NYSE: ABT) looks attractive at current levels of $120, despite the stock rising 2x from levels of $62 it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks an outperformance compare...
-
These Stocks Can Offer Higher Returns Compared To Abbott Labs
We believe that there are several stocks in the healthcare sector that are better than Abbott Labs (NYSE:ABT) . Abbott’s current market cap-to-operating income ratio of 41x compares with 12x for Emergent Biosolutions (EBS), 19x for Vertex P...
-
Can Abbott Stock Trade Higher Post Q4 Results?
Abbott stock (NYSE: ABT) is scheduled to report its Q4 2020 results on Wednesday, January 27. We expect Abbott to likely report mixed results with revenues slightly below and earnings in-line with the consensus estimates, driven by a rebound in d...
-
Despite A 70% Rally Abbott Stock Can Continue Higher
Abbott stock (NYSE: ABT) is up 23% since the start of the year and it has gained around 70% from its March lows. We believe that Abbott could offer an upside in the near term, as the company’s revenues in the last three quarters have actually gro...
-
Quidel, Abbott, Quest: Why Covid-19 Testing Stocks Are Still Worth A Look
Our indicative theme of Covid-19 Testing Stocks – which includes the stocks of companies that produce or carry out tests for the highly infectious virus – is up by about 51% year-to-date, on an equally weighted basis, compared to the...
-
Quidel, Abbott, Quest: Testing Stocks To Watch As Covid-19 Cases Surge
Our indicative theme of Covid-19 Testing Stocks, which includes medical device and diagnostic companies that are involved in Covid-19 testing – is up by about 66% year-to-date, significantly outperforming the S&P 500 which has gained about 3...
-
Continue To Ride Abbott Stock In The Current Pandemic
Abbott’s stock (NYSE: ABT) lost more than 27% – dropping from $87 at the beginning of the year to below $63 in late March – then spiked 66% to around $105 now. That means it is well above the levels where it started the year. Why? Abbott secu...
-
Covid Testing Stocks To Watch As The Holidays Near
Our indicative theme of Covid-19 Testing Stocks, which includes medical devices and diagnostic companies that are involved in Covid-19 testing – is up by about 69% year-to-date, significantly outperforming the S&P 500 which is up by ab...
-
Is The Rally Over For Abbott Stock?
Abbott Labs’ stock (NYSE:ABT) trades at $107 currently and it has gained 24% in value so far this year. It traded at a pre-Covid high of $89 in February, and it is currently 20% higher than that level. Also, ABT stock has gained 71% from th...
-
Despite 60% Rally Abbott Stock Still Has Room To Grow
Abbott’s stock (NYSE: ABT) lost more than 27% – dropping from $87 at the beginning of the year to below $63 in late March – then spiked 58% to around $100 now. That means it is well above the levels where it started the year. Why? Abbott secu...
